Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells

European Journal of Pharmacology
P A CahillJ V Sitzmann

Abstract

The objective of this study was to determine whether an enhanced generation of nitric oxide (NO) causes regulation of angiotensin II receptors in vitro using rat vascular smooth muscle cells in culture. Chronic treatment of cells with a series of NO-generating drugs, sodium nitroprusside, S-nitroso-N-acetylpenicillamine and isosorbide dinitrate for 18h dose and time-dependently decreased [125I]-angiotensin II binding to cells without any significant change in affinity. Induction of nitric oxide synthase following lipopolysaccharide (10 and 100 ng/ml) treatment of cells for 18 h increased basal nitric oxide synthase activity with a concomitant increase of nitrite and cyclic cGMP levels in the conditioned media. LPS treatment significantly (P < 0.05) decreased [125I]-angiotensin II binding to these cells, an effect that was significantly (P < 0.05) attenuated in the presence of NG-nitro-L-arginine methyl ester. In contrast, treatment of cells with atrial natriuretic factor, dibutyryl cGMP, 8-bromo-cGMP, NaNO2 or NaNO3 failed to significantly alter the affinity or number of [125I]-angiotensin II binding sites. These results suggest that NO regulates angiotensin II receptors in vitro through a cGMP-independent mechanism.

References

Oct 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Y LeeR J Groszmann
May 29, 1992·Biochemical and Biophysical Research Communications·N MakitaK F Badr
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
May 31, 1991·Biochemical and Biophysical Research Communications·N IwaiT Inagami
Jun 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J Reichen
Jan 1, 1990·Pharmacology & Therapeutics·F Ballet
Sep 1, 1989·The Journal of Surgical Research·J V SitzmannP W Lin
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Jul 1, 1993·Journal of Neurochemistry·O Manzoni, J Bockaert
Jan 1, 1994·Life Sciences·B BrüneE G Lapetina
Aug 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A CastroJ Rodés

❮ Previous
Next ❯

Citations

Aug 8, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P A CahillJ V Sitzman
Jan 1, 1997·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·J LiY Hu
Aug 3, 2005·Cellular and Molecular Neurobiology·Juan M Saavedra
Aug 23, 2001·Pharmacology & Therapeutics·P W Hadoke
Feb 9, 2000·Pharmacology & Therapeutics·B WeinbergerJ D Laskin
Jul 8, 1999·Regulatory Peptides·L J MillattH M Siragy
Nov 1, 1996·British Journal of Pharmacology·E Millette, D Lamontagne
Jan 6, 2012·American Journal of Physiology. Cell Physiology·Neeru M SharmaKaushik P Patel
Dec 2, 2006·American Journal of Respiratory and Critical Care Medicine·Fabrício Rios-SantosFernando de Queiroz Cunha
Mar 28, 2006·British Journal of Pharmacology·Patrice C LeclercGaetan Guillemette
Feb 27, 2003·Clinical and Experimental Pharmacology & Physiology·Alice A O BricolaGilberto De Nucci
Jul 14, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Maria KamperElli F Kamper
Sep 12, 2006·Free Radical Biology & Medicine·Marcel Bassil, Madhu B Anand-Srivastava
Mar 1, 1996·Journal of Cellular Physiology·E M RedmondJ V Sitzmann
Mar 7, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Haruki YamakawaJuan M Saavedra
Jun 17, 2004·American Journal of Physiology. Endocrinology and Metabolism·Kasem NithipatikomWilliam B Campbell
Sep 19, 2009·Circulation Research·Bhama RamkhelawonStéphanie Lehoux
Jul 1, 1997·Hypertension·H SasamuraT Saruta
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Chen YanBradford C Berk
Aug 18, 2001·Hypertension·M BucherA Kurtz
Aug 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J V SitzmannR C Burns
Aug 30, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Eva Nozik-GrayckClaude A Piantadosi
Dec 3, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yi-Fan LiKaushik P Patel
Sep 17, 2010·International Journal of Geriatric Psychiatry·Lingli YangLingjiang Li
Oct 20, 1999·Journal of Hypertension·M S Fernández-Alfonso, C González
Oct 31, 1998·Journal of Hypertension·A Sánchez-MendozaB Escalante
Apr 12, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Eva Nozik-GrayckClaude A Piantadosi
Oct 2, 1998·The American Journal of Physiology·P T Nowicki
Dec 21, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·K M ReberP T Nowicki
Sep 15, 2020·European Journal of Pharmacology·Upinder KaurSankha Shubhra Chakrabarti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.